Biotechnology in the US - Industry Risk Rating ReportIBISWorldJanuary 22, 2012 25 Pages - SKU: IBSS6826421 |
| Countries covered: United States This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk). This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months. Industry Definition Firms in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies primarily involved in developing pharmaceuticals, performing contract research or manufacturing biological equipment. Report Contents Risk Overview The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score. Structural Risk The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry’s level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section. Growth Risk The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both. Sensitivity Risk The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate. Industry Risk and Industry Risk Scoring Methodology This chapter provides an overview of how IBISWorld defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk. Biotechnology in the US 62151 - Diagnostic & Medical Laboratories in the US 32531 - Fertilizer Manufacturing in the US 31111 - Animal Food Production in the US 31191 - Snack Food Production in the US 33911a - Medical Instrument & Supply Manufacturing in the US 33911b - Glasses & Contact Lens Manufacturing in the US 54171 - Scientific Research & Development in the US 54194 - Veterinary Services in the US |
More United States Biotechnology Reports
2012 US Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, ...
Biotechnology Product Manufacturing by
First Research, Inc.
Brief Excerpt from Industry Overview Chapter: The US biotechnology product manufacturing industry includes about 1,500 companies with combined annual revenue of more than $90 billion. Major ...
US Wound Care Market Assessment and Forecasts to 2018 by
ABMRG
The Market Intelligence report provides critical market data for US wound care market and its product categories. The data includes market size in terms of ...
Analysis of the U.S. Sensory Ingredients in Animal Feed Market by
Frost & Sullivan
This research service covers the market for sensory ingredients in animal feed in the United States. The service considers flavor and pigment ingredients. Furthermore, the ...
Wound Care in the US by
Euromonitor International
As consumers emerge from one of the most severe recessions in US history, they remain highly price-sensitive and are focused on getting the best value ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
Biotechnology Reports
- Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
- Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
